HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Industrial Cannabis/Industrial Hemp

417.247

-5.145-1.22%

Number of Gainers:3

Number of Losers:3

Number of Flat:1

PE:- -

High:422.393

Open:422.393

Low:414.253

Close:422.393

Volume:16.18M

Turnover:12.54M

Market Cap:17.07B

Float Cap:17.07B

Loading ...

Meilleure Health International Sees 261 Million Share Transfer as Position Shift Totals HK$56.3 Million

Sihuan Pharma Unit Gets China Nod for Five New Specifications of Skin Booster

MT Newswires Live

SIHUAN PHARM (00460): Additional Specifications of "Dongyan" Skin Booster Approved for Market Launch by National Medical Products Administration

Sihuan Pharma - Five New Specifications of Dongyan Skin Booster Approved for Launch by Nmpa

THOMSON REUTERS

China Carbon Neutral Development - FY Loss Attributable Hkd185.4 Mln

THOMSON REUTERS

China Carbon Neutral Development Group (SEHK:1372) Stock Hit By Profit Reversal

Simply Wall St.

C CARBONNEUTRAL (01372) Reports Annual Results: Shareholder-Attributable Loss Reaches HK$185 Million, Up 2388% Year-on-Year

Chairman and CEO Zhang Youcang Raises Stake in Evergreen PG (01962) by 18,000 Shares at HK$0.47 Each

Chairman and CEO Zhang Youcang Increases Stake in EVERGREEN PG (01962) by 50,000 Shares at HK$0.47 Each

China Carbon Neutral Development Group - Expects Net Loss for Year Ended June 30, 2026 Including Hk$160 Mln-Hk$200 Mln Debt Restructuring Loss

THOMSON REUTERS

LifeTech Scientific's Stent Graft System Included in Chinese Regulators' Special Examination Procedure

MT Newswires Live

Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices

Lifetech Scientific Says Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure

LifeTech Scientific - Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure

THOMSON REUTERS

Meilleure Health to Acquire Property Investment Company

MT Newswires Live

Meilleure Health International Industry to Buy Tech-Medi Development for Hk$35.2 Mln

Meilleure Health International (02327) to Acquire Full Stake in Dexin Pharma Development for HK$35.2 Million

Meilleure Health International Industry Group - to Buy Target Company for Hk$35.2 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK1600/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"Industrial Cannabis/Industrial Hemp","latestPrice":417.24734,"timestamp":1791360530318,"preClose":422.39252,"halted":0,"volume":16175000,"delay":0,"changeRate":-0.012181,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-5.145172,"latestTime":"10-07 16:00:00","open":422.39252,"high":422.39252,"low":414.2528,"amount":12539419,"amplitude":0.01927,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791336600000,1791345600000],[1791349200000,1791360000000]],"pbRate":1.217606,"peRate":54.024603,"turnoverRate":0.000517,"increases":3,"decrements":3,"flats":1,"marketCap":17068242184,"floatMarketCap":17068242184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":422.39252,"amplitude":0.01927,"preClose":422.39252,"low":414.2528,"pbRate":"1.217606","latestPrice":417.24734,"volume":16175000,"delay":0,"open":422.39252,"prevYearClose":572.4504,"prevWeekClose":416.292,"prevMonthClose":431.358,"prevQuarterClose":431.358,"fiveDayClose":430.023,"twentyDayClose":454.839,"sixtyDayClose":478.635,"secType":"PLATE","market":"HK","turnoverRate":0.000517,"peRate":54.024603,"marketCap":17068242184,"floatMarketCap":17068242184,"timestamp":1791360530318,"nameCN":"Industrial Cannabis/Industrial Hemp"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":3,"down":3,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158981598","title":"Meilleure Health International Sees 261 Million Share Transfer as Position Shift Totals HK$56.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1158981598","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158981598?lang=en_us&edition=fundamental","pubTime":"2026-10-06 08:51","pubTimestamp":1791247865,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, Meilleure Health International (02327) experienced a position change on October 5, with a total transfer value of HK$56.2962 million,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000166","BK0028","161027","BK0276","BK1124","BK1600","02327","06806","BK0183","BK1147","BK1564","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673709413","title":"Sihuan Pharma Unit Gets China Nod for Five New Specifications of Skin Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2673709413","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673709413?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:13","pubTimestamp":1791195199,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical  said five new specifications of the Hyaluronic Acid Sodium Composite Solution for Injection were approved for launch by China's National Medical Products Administration.The composite solution skin booster was developed by unit Meiyan Space Biotechnology , a Monday bourse filing showed.The specification expansion will allow adaptation to diverse skin needs and clinical application scenarios among other benefits.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","00460","BK1600","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108727369","title":"SIHUAN PHARM (00460): Additional Specifications of \"Dongyan\" Skin Booster Approved for Market Launch by National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=1108727369","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108727369?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:08","pubTimestamp":1791191297,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that five additional specifications of its self-developed sodium hyaluronate composite solution for injection (skin booster, trade name: Dongyan), developed by its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","IPOS","BK1191","00460","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673054037","title":"Sihuan Pharma - Five New Specifications of Dongyan Skin Booster Approved for Launch by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2673054037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673054037?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:56","pubTimestamp":1791190581,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45Q03V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00460","BK1593","BK1600","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672195713","title":"China Carbon Neutral Development - FY Loss Attributable Hkd185.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2672195713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672195713?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:20","pubTimestamp":1790932846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nPLXTC3R2H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1144","BK1594","BK1600","BK1148","01372"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672674777","title":"China Carbon Neutral Development Group (SEHK:1372) Stock Hit By Profit Reversal","url":"https://stock-news.laohu8.com/highlight/detail?id=2672674777","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672674777?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:26","pubTimestamp":1790882782,"startTime":"0","endTime":"0","summary":"China Carbon Neutral Development Group closed at HK$1.055 on 30 September, capping a tough month in which the share price fell about 22% even as the 90 day return remained positive. The latest full year numbers explain why the mood soured. A sharp swing into loss in the second half, with basic earnings per share dropping to a deficit of HK$0.286798 and net income turning to a loss of HK$211.054 million, puts the profit squeeze front and center and forces investors to focus less on the next...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice2-card/1788934498909","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/3041000-choice2-card/1788934498909"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/capital-goods/hkg-1372/china-carbon-neutral-development-group-shares/news/china-carbon-neutral-development-group-sehk1372-stock-hit-by","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/capital-goods/hkg-1372/china-carbon-neutral-development-group-shares/news/china-carbon-neutral-development-group-sehk1372-stock-hit-by","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1594","BK1600","BK1148","BK1144","01372"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152687282","title":"C CARBONNEUTRAL (01372) Reports Annual Results: Shareholder-Attributable Loss Reaches HK$185 Million, Up 2388% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1152687282","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152687282?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:08","pubTimestamp":1790777292,"startTime":"0","endTime":"0","summary":"C CARBONNEUTRAL (01372) has released its annual results for the year ended 30 June 2026.The group recorded revenue of HK$637 million, representing a year-on-year increase of 10.01%.Loss attributable...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1144","BK1600","BK1594","BK1148","01372"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197561903","title":"Chairman and CEO Zhang Youcang Raises Stake in Evergreen PG (01962) by 18,000 Shares at HK$0.47 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1197561903","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197561903?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:52","pubTimestamp":1790769150,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 29, Chairman and CEO Zhang Youcang increased his holdings in Evergreen PG (01962) by 18,000 shares at HK$0.47 per share,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","01962","BK1585","BK1600","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178643191","title":"Chairman and CEO Zhang Youcang Increases Stake in EVERGREEN PG (01962) by 50,000 Shares at HK$0.47 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1178643191","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178643191?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:34","pubTimestamp":1790681655,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 28, Chairman and CEO Zhang Youcang increased his holdings in EVERGREEN PG (01962) by 50,000 shares at HK$0.47 per share,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","BK1207","BK1585","BK1600","01962"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239836","title":"China Carbon Neutral Development Group - Expects Net Loss for Year Ended June 30, 2026 Including Hk$160 Mln-Hk$200 Mln Debt Restructuring Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239836?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:38","pubTimestamp":1790591922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1148","01372","BK1144","BK1594","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498202","title":"LifeTech Scientific's Stent Graft System Included in Chinese Regulators' Special Examination Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498202","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669498202?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:49","pubTimestamp":1790254143,"startTime":"0","endTime":"0","summary":"LifeTech Scientific's  SureCham Aortic Arch Single-Branch Stent Graft System was admitted into the special examination and approval procedure for innovative medical devices by China's National Medical Products Administration.The device was co-developed with Shu Chang's team at Fuwai Hospital, the Chinese Academy of Medical Sciences of the National Center for Cardiovascular Diseases, a Thursday bourse filing showed.The product is indicated for the treatment of aortic dissection involving the aortic arch.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1100","BK1600","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104658454","title":"Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1104658454","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104658454?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:16","pubTimestamp":1790252179,"startTime":"0","endTime":"0","summary":"Lifetech Scientific (01302) has announced that on September 24, 2026, the company received formal written notification from the National Medical Products Administration confirming that the SureCham...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDEV","LNGR","PTH","09996","MEDX","GDOC","AGNG","HART","IEIH","BK1600","LGHT","01302","RSPH","159883","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669546048","title":"Lifetech Scientific Says Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669546048","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669546048?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:10","pubTimestamp":1790251835,"startTime":"0","endTime":"0","summary":"Sept 24 (Reuters) - LifeTech Scientific Corp <1302.HK>::*SURECHAMTM STENT GRAFT ADMITTED TO NMPA SPECIAL EXAMINATION AND APPROVAL PROCEDURE*Further company coverage: 1302.HK* ((reuters.briefs@thomsonr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nRSD8rhpj1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1600","BK1583","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460835","title":"LifeTech Scientific - Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460835?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:57","pubTimestamp":1790251057,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1600","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669774157","title":"Meilleure Health to Acquire Property Investment Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2669774157","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669774157?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:47","pubTimestamp":1789987626,"startTime":"0","endTime":"0","summary":"A unit of Meilleure Health International Industry Group  agreed to acquire Tech-Medi Development from Yee Sheng Enterprises.Unit Meilleure Group Development will make the purchase for HK$35.2 million, a Monday bourse filing showed.The target engages mainly in property investment and leasing, with a Grade A commercial property in Admiralty, Hong Kong, as a core asset.The company plans to use the premises as its own office in a bid to reduce rental expenses and boost operational stability.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRT.SI","BK1600","BK1124","CLR.SI","GLS.SI","02327","SRU.SI","CFA.SI","JJJ.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669573711","title":"Meilleure Health International Industry to Buy Tech-Medi Development for Hk$35.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2669573711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669573711?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:25","pubTimestamp":1789986350,"startTime":"0","endTime":"0","summary":"BRIEF-Meilleure Health International Industry To Buy Tech-Medi Development For HK$35.2 MlnSept 21 (Reuters)-Meilleure Health International Industry Group Ltd2327.HK:TO BUY TARGET COMPANY FOR HK$35.2 MILLIONTARGET COMPANY REFERS TO TECH-MEDI DEVELOPMENTFurther company coverage:2327.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0QY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1124","BK1600","02327"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127039540","title":"Meilleure Health International (02327) to Acquire Full Stake in Dexin Pharma Development for HK$35.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1127039540","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127039540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:08","pubTimestamp":1789985317,"startTime":"0","endTime":"0","summary":"Meilleure Health International (02327) has announced that on September 21, 2026, after trading hours, the company entered into an agreement with the seller, Yucheng Industrial Limited. Under this...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1124","02327","BK1515","BK1600","09939","BK1161","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669815284","title":"Meilleure Health International Industry Group - to Buy Target Company for Hk$35.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2669815284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669815284?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:55","pubTimestamp":1789984549,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0QY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02327","BK1600","BK1124"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}